pharmaceuticals

This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif.
Ben Margot/AP Photo, File
AP News
June 29, 2020 - 12:55 pm
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.
Read More
A surgical mask and an N95 mask hang on display for sale at a pharmacy during the novel coronavirus crisis on April 22, 2020.
Sean Gallup/Getty Images
Paul Kurtz
May 12, 2020 - 4:10 pm
A new black market has emerged since the arrival of the coronavirus, and it’s been keeping U.S Customs and Border Protection officials busy. Read more here.
Read More
An arrangement of hydroxychloroquine pills in Las Vegas, April 6, 2020.
John Locher/AP Photo
AP News
April 21, 2020 - 12:27 pm
A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine versus standard care, researchers reported. Read more here.
Read More
A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States.
Gilead Sciences via AP
AP News
April 06, 2020 - 11:34 am
Coronavirus patients around the world have been rushing to join remdesivir studies that opened in hospitals in the last few weeks. Read more here.
Read More
Graphic of pill filled with earths
pavelis/Getty Images
Rasa Kaye
January 13, 2020 - 3:00 pm
Members of the medical community are keeping a weather eye on how our rapidly warming world is already challenging our physical well-being — and how that may change how they respond to the increased demand for drugs to treat climate change’s exacerbation of health problems. Read more here.
Read More
Summit county executive Ilene Shapiro speaks to the media outside the U.S. Federal courthouse, Monday, Oct. 21, 2019, in Cleveland.
David Dermer/AP Photo
AP News
October 21, 2019 - 10:04 am
The nation's three biggest drug distributors and a major drugmaker reached an 11th-hour, $260 million settlement over the toll of the opioids in two Ohio counties, averting what would have been the first federal trial over the crisis. The settlement was announced just hours before the trial was...
Read More
OxyContin
Toby Talbot/AP, file
AP News
August 28, 2019 - 12:54 pm
COLUMBUS, Ohio (AP) — Purdue Pharma and the thousands of state and local governments suing the maker of OxyContin over the nation's deadly opioid crisis are negotiating a $10 billion to $12 billion settlement under which the Sackler family would give up ownership of the company, according to...
Read More
Hand holding bottle of Cannabis oil against Marijuana plant
MysteryShot/Getty Images
June 20, 2019 - 9:44 am
By Alicia Wallace, CNN Business (CNN) — Fueled in part by CBD product sales and Canada's recent legalization of marijuana, the world's cannabis market could notch $15 billion this year. Industry insiders are forecasting that global cannabis sales could total $14.9 billion in 2019, up 36% from 2018...
Read More
MDMA
Drug Enforcment Adminstration
May 02, 2018 - 8:03 am
By Susan Scutti, CNN (CNN) -- MDMA -- the active ingredient in the banned street drug ecstasy -- is safe and enhances the treatment of post-traumatic stress disorder when administered during psychotherapy, according to a new clinical trial. More research is needed to fully assess the drug, caution...
Read More